相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2023)
Comprehensive registry of esophageal cancer in Japan, 2015
Masayuki Watanabe et al.
ESOPHAGUS (2023)
Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. G. Casali et al.
ANNALS OF ONCOLOGY (2022)
Clinical characteristics and treatment outcomes of primary malignant melanoma of esophagus: a single center experience
Tae-Se Kim et al.
BMC GASTROENTEROLOGY (2022)
Pimitespib in patients with advanced gastrointestinal stromal tumor (CHAPTER-GIST-301): a randomized, double-blind, placebo-controlled phase III trial
Y. Kurokawa et al.
ANNALS OF ONCOLOGY (2022)
The Thousand Faces of Malignant Melanoma: A Systematic Review of the Primary Malignant Melanoma of the Esophagus
Gerardo Cazzato et al.
CANCERS (2022)
Mixed Neuroendocrine Non-Neuroendocrine Neoplasm Arising in the Ectopic Gastric Mucosa of Esophagus
Ryosuke Gushima et al.
CASE REPORTS IN GASTROENTEROLOGY (2022)
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System The TOPIC-NEC Phase 3 Randomized Clinical Trial
Chigusa Morizane et al.
JAMA ONCOLOGY (2022)
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System The TOPIC-NEC Phase 3 Randomized Clinical Trial
Chigusa Morizane et al.
JAMA ONCOLOGY (2022)
Complete remission in metastatic primary malignant melanoma of the esophagus with nivolumab: a case report
Takeshi Okamoto et al.
JOURNAL OF MEDICAL CASE REPORTS (2021)
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
Stephen Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
The management of metastatic GIST: current standard and investigational therapeutics
Ciara M. Kelly et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)
Y. Nakamura et al.
ESMO OPEN (2021)
Esophageal Carcinosarcoma: Analysis of Clinical Features and Prognosis of 24 Cases and a Literature Review
Shusen Chen et al.
CANCER CONTROL (2021)
Carcinosarcoma of the Thoracic Esophagus That Presented as Focal Ulcerative Lesion
Akira Yoneda et al.
CASE REPORTS IN GASTROENTEROLOGY (2021)
Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case report
Shingo Ito et al.
JOURNAL OF MEDICAL CASE REPORTS (2021)
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up y
M. Pavel et al.
ANNALS OF ONCOLOGY (2020)
Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy
Yoshitaka Honma et al.
CANCER MEDICINE (2020)
Multiple carcinosarcomas of the esophagus with adeno-carcinomatous components: A case report
Hiroshi Okamoto et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Treatment and prognosis of primary malignant melanoma of the esophagus
Lei Cheng et al.
TRANSLATIONAL CANCER RESEARCH (2020)
Characteristics and prognosis of primary malignant melanoma of the esophagus
Hengchi Chen et al.
MEDICINE (2020)
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial
Paolo A. Ascierto et al.
LANCET ONCOLOGY (2020)
Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study
Toshihiko Masui et al.
BMC CANCER (2020)
Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors
Jerzy Lasota et al.
MODERN PATHOLOGY (2019)
Primary malignant melanoma of the esophagus: A retrospective analysis of clinical features, management, and survival of 76 patients
Xuan Wang et al.
THORACIC CANCER (2019)
Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2
Yuko Kitagawa et al.
ESOPHAGUS (2019)
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Luis Paz-Ares et al.
LANCET (2019)
Esophageal carcinosarcoma that disappeared pathologically by palliative radiotherapy alone
Keiichi Kimura et al.
CLINICAL JOURNAL OF GASTROENTEROLOGY (2019)
Esophageal Carcinosarcoma with Basaloid Squamous Cell Carcinoma: A Case Report and Review of the Literature
Hirotaka Ishida et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Systematic review of case reports of Japanese esophageal neuroendocrine cell carcinoma in the Japanese literature
Yoshinori Kikuchi et al.
INTERNATIONAL CANCER CONFERENCE JOURNAL (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
Frank Stephen Hodi et al.
LANCET ONCOLOGY (2018)
Gastrointestinal stromal tumor of the esophagus: current issues of diagnosis, surgery and drug therapy
Jun Hihara et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumors
Amber E. Bannon et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
Gastrointestinal stromal tumours of the oesophagus: a clinicopathological and molecular analysis of 27 cases
Guhyun Kang et al.
HISTOPATHOLOGY (2017)
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis
Sandra P. D'Angelo et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms
Louis de Mestier et al.
NEUROENDOCRINOLOGY (2017)
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
J. Weber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Primary malignant melanoma of the esophagus treated with subtotal esophagectomy: a case report
Shota Kuwabara et al.
BMC SURGERY (2017)
Management of esophageal gastrointestinal stromal tumor: review of one hundred seven patients
K. Pence et al.
DISEASES OF THE ESOPHAGUS (2017)
8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice
Thomas W. Rice et al.
ANNALS OF CARDIOTHORACIC SURGERY (2017)
Clinicopathologic Features and Clinical Outcomes of Esophageal Gastrointestinal Stromal Tumor Evaluation of a Pooled Case Series
Fan Feng et al.
MEDICINE (2016)
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
R. Garcia-Carbonero et al.
NEUROENDOCRINOLOGY (2016)
Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection
Han-Yu Deng et al.
JOURNAL OF THORACIC DISEASE (2016)
Clinicopathological Profile of Pure Neuroendocrine Neoplasms of the Esophagus: A South Indian Center Experience
Govind Babu Kanakasetty et al.
JOURNAL OF ONCOLOGY (2016)
Efficacy and Safety of Carboplatin and Etoposide Combination Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma: A Retrospective Case Series
Hiroo Imai et al.
CHEMOTHERAPY (2015)
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma
J. Hadoux et al.
ENDOCRINE-RELATED CANCER (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Wide expression of ZEB1 in sarcomatous component of spindle cell carcinoma of the esophagus
Takuro Nakazawa et al.
PATHOLOGY INTERNATIONAL (2015)
Diagnosis and surgical treatment of esophageal gastrointestinal stromal tumors
Fang-Biao Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Giant esophageal gastrointestinal stromal tumor: report of a case
Akira Nakano et al.
SURGERY TODAY (2015)
Oesophageal GIST-A rare breed case report and review of the literature
Kristof Nemeth et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2015)
Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review
Emma Elizabeth Ilett et al.
DIAGNOSTICS (2015)
Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system
Tomohiro Yamaguchi et al.
CANCER SCIENCE (2014)
A Case of Carcinosarcoma of the Esophagus Detected on Fluorodeoxyglucose Positron Emission Tomography
Takeshi Matsutani et al.
JOURNAL OF NIPPON MEDICAL SCHOOL (2014)
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
H. Sorbye et al.
ANNALS OF ONCOLOGY (2013)
Esophageal Carcinosarcoma: A Unique Entity with Better Prognosis
Liang Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
George D. Demetri et al.
LANCET (2013)
FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3
O. Hentic et al.
ENDOCRINE-RELATED CANCER (2012)
Current status of primary malignant melanoma of the esophagus: clinical features, pathology, management and prognosis
Yoshimi Iwanuma et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Genetic aberrations in primary esophageal melanomas: molecular analysis of c-KIT, PDGFR, KRAS, NRAS and BRAF in a series of 10 cases
Rupert Langer et al.
MODERN PATHOLOGY (2011)
C-kit-immunopositive interstitial cells of Cajal in human embryonal and fetal oesophagus
Goran Radenkovic et al.
CELL AND TISSUE RESEARCH (2010)
Clinical characteristics and surgical treatment of oesophageal gastrointestinal stromal tumours
Peng Jiang et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
Spindle cell sarcoma of esophagus: A rare case presentation
V Lokesh et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2010)
An esophageal gastrointestinal stromal tumor with regional lymph node metastasis
Sohei Matsumoto et al.
ESOPHAGUS (2010)
An Evaluation of 2537 Gastrointestinal Stromal Tumors for a Proposed Clinical Staging System
Charles E. Woodall et al.
ARCHIVES OF SURGERY (2009)
Phase II Trial of Neoadjuvant/Adjuvant Imatinib Mesylate (IM) for Advanced Primary and Metastatic/Recurrent Operable Gastrointestinal Stromal Tumor (GIST): Early Results of RTOG 0132/ACRIN 6665
Burton L. Eisenberg et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Esophageal melanomas harbor frequent NRAS mutations unlike melanomas of other mucosal sites
Shigeki Sekine et al.
VIRCHOWS ARCHIV (2009)
Risk stratification of patients diagnosed with gastrointestinal stromal tumor
Heikki Joensuu
HUMAN PATHOLOGY (2008)
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT
Charles D. Blanke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Surgical considerations for the management and resection of esophageal gastrointestinal stromal tumors
Matthew G. Blum et al.
ANNALS OF THORACIC SURGERY (2007)
Small cell carcinomas of the gastrointestinal tract: Clinicopathological features and treatment approach
Baruch Brenner et al.
SEMINARS IN ONCOLOGY (2007)
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
George D. Demetri et al.
LANCET (2006)
Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation
VJ Amatya et al.
PATHOLOGY INTERNATIONAL (2004)
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor
MC Heinrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
BRAF as a potential therapeutic target in melanoma and other malignancies
DA Tuveson et al.
CANCER CELL (2003)
PDGFRA activating mutations in gastrointestinal stromal tumors
MC Heinrich et al.
SCIENCE (2003)
Small cell carcinoma of the esophagus: The Tata Memorial Hospital experience
GH Pantvaidya et al.
ANNALS OF THORACIC SURGERY (2002)
分享论文
